XML 18 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
CHINA GEWANG BIOTECHNOLOGY, INC.- Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Retained Earnings
Noncontrolling Interests
Statutory Reserve Fund
Other Comprehensive Income (Loss)
Total
Balance, amount at Nov. 30, 2013 $ 35,500 $ 1,539,275 $ 592,024 $ 16,113 $ 65,089 $ 61,665 $ 2,309,666
Net income     761,313 22,839     784,152
Statutory reserve     (76,131)   76,131    
Other comprehensive income     67     1,266 1,333
Balance, amount at Nov. 30, 2014 35,500 1,539,275 1,277,273 38,952 144,454 62,998 3,098,452
Net income     1,126,923 61,790     1,188,713
Statutory reserve     (137,312)   137,312    
Other comprehensive income       (16,581)   (315,020) (331,601)
Reverse merger adjustment   (3,532) 3,532        
Issuance of Common Stock 10,000 4,990,000         5,000,000
Balance, amount at Nov. 30, 2015 $ 45,500 $ 6,525,743 $ 2,270,416 $ 84,161 $ 281,766 $ (252,022) $ 8,955,564